A patient with stage 4 chronic kidney disease (CKD) has a persistent serum potassium of 6.0 mmol/L despite dietary modifications and stopping ACE inhi...

Question

A patient with stage 4 chronic kidney disease (CKD) has a persistent serum potassium of 6.0 mmol/L despite dietary modifications and stopping ACE inhibitors. Which agent can help control hyperkalaemia in this context?

Accepted Answer

C. Oral sodium zirconium cyclosilicate

Answer

A. Intravenous insulin and glucose

Answer

B. Beta-2 agonists nebulisation

Answer

D. Oral sodium bicarbonate

Answer

E. Urgent haemodialysis only

MCQ (SBA): Chronic Kidney Disease

A patient with stage 4 chronic kidney disease (CKD) has a persistent serum potassium of 6.0 mmol/L despite dietary modifications and stopping ACE inhibitors. Which agent can help control hyperkalaemia in this context?